已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial

医学 心房颤动 烧蚀 心脏病学 射频消融术 内科学
作者
Jason G. Andrade,Jean Champagne,Marc Dubuc,Marc William Deyell,Atul Verma,Laurent Macle,Peter Leong‐Sit,PAUL G. NOVAK,Mariano Badra‐Verdu,John L. Sapp,Iqwal Mangat,Clarence Khoo,Christian Steinberg,Matthew T. Bennett,ANTHONY S.L. TANG,Paul Khairy,For the CIRCA-DOSE Study Investigators,Ratika Parkash,Peter G. Guerra,Katia Dyrda
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:140 (22): 1779-1788 被引量:620
标识
DOI:10.1161/circulationaha.119.042622
摘要

Background: Advanced generation ablation technologies have been developed to achieve more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence after atrial fibrillation (AF) ablation. Methods: We randomly assigned 346 patients with drug-refractory paroxysmal AF to contact force–guided radiofrequency ablation (CF-RF; n=115), 4-minute cryoballoon ablation (Cryo-4; n=115), or 2-minute cryoballoon ablation (Cryo-2; n=116). Follow-up was 12 months. The primary outcome was time to first documented recurrence of symptomatic or asymptomatic atrial tachyarrhythmia (AF, atrial flutter, or atrial tachycardia) between days 91 and 365 after ablation or a repeat ablation procedure at any time. Secondary end points included freedom from symptomatic arrhythmia and AF burden. All patients received an implantable loop recorder. Results: One-year freedom from atrial tachyarrhythmia defined by continuous rhythm monitoring was 53.9%, 52.2%, and 51.7% with CF-RF, Cryo-4, and Cryo-2, respectively ( P =0.87). One-year freedom from symptomatic atrial tachyarrhythmia defined by continuous rhythm monitoring was 79.1%, 78.2%, and 73.3% with CF-RF, Cryo-4, and Cryo-2, respectively ( P =0.26). Compared with the monitoring period before ablation, AF burden was reduced by a median of 99.3% (interquartile range, 67.8%–100.0%) with CF-RF, 99.9% (interquartile range, 65.3%–100.0%) with Cryo-4, and 98.4% (interquartile range, 56.2%–100.0%) with Cryo-2 ( P =0.36). Serious adverse events occurred in 3 patients (2.6%) in the CF-RF group, 6 patients (5.3%) in the Cryo-4 group, and 7 patients (6.0%) in the Cryo-2 group, with no significant difference between groups ( P =0.24). The CF-RF group had a significantly longer procedure duration but significantly shorter fluoroscopy exposure ( P <0.001 vs cryoballoon groups). Conclusions: In this multicenter, randomized, single-blinded trial, CF-RF and 2 different regimens of cryoballoon ablation resulted in no difference in 1-year efficacy, which was 53% by time to first recurrence but >98% burden reduction as assessed by continuous cardiac rhythm monitoring. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01913522.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
巴山郎完成签到,获得积分10
1秒前
xy完成签到,获得积分20
3秒前
Zora完成签到 ,获得积分10
3秒前
3秒前
李健的应助被aaaol采纳,获得10
3秒前
kk完成签到 ,获得积分10
5秒前
5秒前
领导范儿的应助被认真问柳采纳,获得10
5秒前
Jasper的应助被xy采纳,获得10
7秒前
7秒前
英姑的应助被科研通管家采纳,获得10
7秒前
深情安青的应助被科研通管家采纳,获得10
7秒前
7秒前
华仔的应助被科研通管家采纳,获得10
8秒前
汉堡包的应助被科研通管家采纳,获得10
8秒前
fantasy的应助被科研通管家采纳,获得30
8秒前
作业本的应助被科研通管家采纳,获得10
8秒前
8秒前
CipherSage的应助被堪曼凝采纳,获得10
8秒前
8秒前
minzhao1986完成签到,获得积分10
8秒前
议二完成签到 ,获得积分10
8秒前
11秒前
12秒前
别偷我的外卖了完成签到,获得积分20
13秒前
13秒前
于誉完成签到,获得积分10
13秒前
13秒前
14秒前
15秒前
15秒前
15秒前
Charles完成签到 ,获得积分0
15秒前
777发布了新的文献求助10
18秒前
zzkkzz完成签到,获得积分10
18秒前
18秒前
学术ceo发布了新的文献求助10
19秒前
LH完成签到,获得积分10
20秒前
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189722
求助须知:如何正确求助?哪些是违规求助? 9576968
关于积分的说明 21850792
捐赠科研通 7787717
什么是DOI,文献DOI怎么找? 3435771
关于科研通互助平台的介绍 2559813
邀请新用户注册赠送积分活动 2482641